LIALDA DR 1.2 GM TABLET

mesalamine
$8.9473per EA
High Outlier

Strength

1.2 g/1

NDC

54092047612

Classification

Brand

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MESALAMINE

Approval Type

New Drug (NDA)

FDA Application

NDA022000

On Market Since

1/16/2007

Pharmacological Classes

Aminosalicylate
Aminosalicylic Acids

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

-0.2%

1Y

-0.4%

3Y

-0.5%

5Y

-0.1%

All

+45.9%